David Rosenbaum - May 28, 2021 Form 4 Insider Report for ARDELYX, INC. (ARDX)

Role
Chief Development Officer
Signature
/s/ Elizabeth Grammer, Attorney-in-Fact for David Rosenbaum
Stock symbol
ARDX
Transactions as of
May 28, 2021
Transactions value $
-$22,098
Form type
4
Date filed
6/2/2021, 07:23 PM
Previous filing
May 21, 2021
Next filing
Aug 24, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARDX Common Stock Sale -$22.1K -3.06K -10.27% $7.22 26.8K May 28, 2021 By Wife F1, F2
holding ARDX Common Stock 77.6K May 28, 2021 Family Trust F3
holding ARDX Common Stock 159K May 28, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was executed in multiple trades in prices ranging from $7.215 to $7.221, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F2 The shares are directly held by the Reporting Person's wife.
F3 The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.